Related Experiment Video
Updated: Jul 24, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.0K
Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA
Lin Yang1, Jin Wang1,2, Jennifer Altreuter1
1Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Nature Protocols
|June 30, 2023
Summary
This tutorial simplifies tumor immune characterization using RNA-sequencing (RNA-seq) data. It introduces computational tools and the RIMA pipeline to make complex analyses accessible for cancer research.
Area of Science:
- Oncology
- Bioinformatics
- Immunology
Background:
- RNA-sequencing (RNA-seq) is a cost-effective method for tumor molecular profiling and immune characterization.
- Numerous computational tools exist for analyzing gene expression data in cancer immunology.
- Analyzing large-scale RNA-seq data demands significant bioinformatics expertise and computational resources.
Purpose of the Study:
- To provide an overview of computational analysis for tumor immune characterization using bulk RNA-seq data.
- To introduce essential computational tools relevant to cancer immunology and immunotherapy.
- To present the RNA-seq IMmune Analysis (RIMA) pipeline for streamlined analysis and a user-friendly guide.
Main Methods:
- Overview of computational analysis strategies for bulk RNA-seq in tumor immunology.
- Introduction to diverse computational tools for evaluating expression signatures, immune infiltration, immune repertoire, immunotherapy response prediction, neoantigen detection, and microbiome quantification.
- Description of the RIMA pipeline, integrating multiple tools for efficient RNA-seq analysis.
Main Results:
- The RIMA pipeline integrates various computational tools for comprehensive tumor immune characterization.
- A user-friendly GitBook guide with demos is available for analyzing RNA-seq data at sample and cohort levels.
- The tutorial aims to lower the barrier for researchers in utilizing RNA-seq for cancer immunology studies.
Conclusions:
- Computational analysis of bulk RNA-seq data is crucial for understanding tumor immunity.
- The RIMA pipeline and accompanying guide facilitate accessible and efficient immune characterization from RNA-seq data.
- This resource empowers researchers to leverage RNA-seq for advancing cancer immunology and immunotherapy research.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
RNA-seq
10.1K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.1K

